Application Value of Quantitative Parameters of Renal Contrast-Enhanced Ultrasound in Monitoring Renal Function in Patients with Sepsis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2600126430

Enrollment

Unknown

Registered

2026-06-09

Start date

2026-06-20

Completion date

Unknown

Last updated

2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Acute kidney injury group and non-acute kidney injury group:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. Meet the Sepsis-3.0 diagnostic criteria; 3. Informed consent obtained from the patient or their legal guardian.

Exclusion criteria

Exclusion criteria: 1. History of chronic kidney disease, post-renal transplantation, known renovascular disease, or urinary tract obstruction; 2. Use of VA-ECMO or high-dose vasoactive agents (norepinephrine > 1 µg/kg/min) at the time of contrast-enhanced ultrasound and TGFR measurement; 3. Pregnancy or lactation; 4. Allergy to ultrasound contrast agents; 5. Poor ultrasound image quality that cannot be analyzed.

Design outcomes

Primary

Measure	Time frame
Quantitative parameters of renal contrast-enhanced ultrasound;Transdermal measurement of glomerular filtration rate;	—

Countries

China

Contacts

Public ContactZhu Weihua

Department of Critical Care Medicine, Second Affiliated Hospital of Kunming Medical University

13508710133@139.com+86 135 0871 0133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026